FIELD: medicine.
SUBSTANCE: medication contains thrombin-like enzyme, as well as to method of reduction of side effect and to application. Thrombin-like enzyme represents protease, generating fibrin I from fibrinogen, in particular, batroxobin.
EFFECT: efficient reduction of side effects, such as suppression of bone marrow or cardiotoxicity.
14 cl, 5 ex, 4 dwg
Authors
Dates
2012-12-20—Published
2008-12-12—Filed